Activity Report & Appendix 4C Q4 FY2025
Filed with ASX · · 7 pages · English
Summary by 6ix AI
The report indicates that the company achieved a positive operating cash flow, attributed to a successful business restructuring and strong sales from its Bouf Haircare products. Additionally, Anagenics is exploring growth opportunities, including potential international expansion and ongoing discussions regarding licensing with Roquefort Therapeutics. The company believes it has sufficient funds to support its operations without needing additional equity funding in the near term.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Anagenics
- YSB Bouf Haircare Continues Strong Performance
- York Street Brands Product Launch
- AN1 - 3Q25 Presentation
- Reinstatement to Quotation
- AN1 - Pre-reinstatement Disclosure
Later from Anagenics
- AN1 FY25-Appendix-4E-Preliminary-Final-Report
- AN1 - FY 2025 Presentation
- Appendix 4C & Activity Report for Q1 FY2026
- Trading Halt
- Placement of Shares
Follow Anagenics into a list and get an email when it puts out news.
Follow Anagenics